Back to User profile » Prof. Dr. Luca Bianchi
Papers published by Prof. Dr. Luca Bianchi:
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
![Plain language summary](assets/img/article_icons/plain-language.png)
Assessing the Beneficial Impact of a Patient Support Program in Secukinumab-Treated Patients with Psoriasis in Italy
Argenziano G, Amerio P, Aragone MG, Baggini G, Baldari M, Castelli G, Coppola S, Costanzo A, De Pasquale R, Fargnoli MC, Foti C, Giofrè C, Lembo S, Leporati C, Loconsole F, Malara G, Peris K, Richetta AG, Savoia P, Tiberio R, Travaglini M, Uzzauto MT, Bianchi L
Patient Preference and Adherence 2021, 15:2551-2562
Published Date: 19 November 2021
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Experimental Pharmacological Management of Psoriasis
Campione E, Cosio T, Di Prete M, Lanna C, Dattola A, Bianchi L
Journal of Experimental Pharmacology 2021, 13:725-737
Published Date: 26 July 2021
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Efficacy of a Topical Product Containing Purified Omental Lipids and Three Anti-Itching Compounds in the Treatment of Chronic Pruritus/Prurigo Nodularis in Elderly Subjects: A Prospective, Assessor-Blinded, 4-Week Trial with Transepidermal Water Loss and Optical Coherence Tomography Assessments
Ardigò M, Franceschini C, Campione E, Cosio T, Lanna C, Bianchi L, Milani M
Clinical, Cosmetic and Investigational Dermatology 2020, 13:1051-1058
Published Date: 30 December 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Small Molecules, Big Promises: Improvement of Psoriasis Severity and Glucidic Markers with Apremilast: A Case Report
Lanna C, Cesaroni GM, Mazzilli S, Bianchi L, Campione E
Diabetes, Metabolic Syndrome and Obesity 2019, 12:2685-2688
Published Date: 17 December 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The Effectiveness of a New Topical Formulation Containing GSH-C4 and Hyaluronic Acid in Seborrheic Dermatitis: Preliminary Results of an Exploratory Pilot Study
![](cr_data/cache/submission_images/s231000/231313/24_oct_2019_fig1_gseba_200_200_90.jpg)
Campione E, Mazzilli S, Lanna C, Cosio T, Palumbo V, Cesaroni G, Lozzi F, Diluvio L, Bianchi L
Clinical, Cosmetic and Investigational Dermatology 2019, 12:881-885
Published Date: 16 December 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Omalizumab for chronic spontaneous urticaria in “complex” patients: data from real-life clinical practice
Vollono L, Piccolo A, Lanna C, Esposito M, Bavetta M, Campione E, Bianchi L, Diluvio L
Drug Design, Development and Therapy 2019, 13:3181-3186
Published Date: 6 September 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Clinical evidence on the efficacy and tolerability of a topical medical device containing benzoylperoxide 4%, retinol 0.5%, mandelic acid 1% and lactobionic acid 1% in the treatment of mild facial acne: an open label pilot study
![](cr_data/cache/submission_images/s182000/182317/15_may_2019_182317_fig1_200_200_90.jpg)
Garofalo V, Cannizzaro MV, Mazzilli S, Bianchi L, Campione E
Clinical, Cosmetic and Investigational Dermatology 2019, 12:363-369
Published Date: 15 May 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Effects of a cream containing 5% hyaluronic acid mixed with a bacterial-wall-derived glycoprotein, glycyrretinic acid, piroctone olamine and climbazole on signs, symptoms and skin bacterial microbiota in subjects with seborrheic dermatitis of the face
Puviani M, Campione E, Offidani AM, De Grandi R, Bianchi L, Bobyr I, Giannoni M, Campanati A, Bottagisio M, Bidossi A, De Vecchi E, Eisendle K, Milani M
Clinical, Cosmetic and Investigational Dermatology 2019, 12:285-293
Published Date: 2 May 2019
![Video](assets/img/article_icons/video.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Spotlight on brodalumab in the treatment of plaque psoriasis: the evidence to date
![](assets/img/youtube_social_icon_dark.png)
![](http://img.youtube.com/vi/XdU4cyB54FY/1.jpg)
Galluzzo M, D'Adamio S, Massaro A, Piccolo A, Bianchi L, Talamonti M
Clinical, Cosmetic and Investigational Dermatology 2019, 12:311-321
Published Date: 1 May 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Effects of topical 0.8% piroxicam and 50+ sunscreen filters on actinic keratosis in hypertensive patients treated with or without photosensitizing diuretic drugs: an observational cohort study
Mazzilli S, Garofalo V, Ventura A, Diluvio L, Milani M, Bianchi L, Campione E
Clinical, Cosmetic and Investigational Dermatology 2018, 11:485-490
Published Date: 12 October 2018
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Antifungal activity of Cardiospermum halicacabum L. (Sapindaceae) against Trichophyton rubrum occurs through molecular interaction with fungal Hsp90
Gaziano R, Campione E, Iacovelli F, Marino D, Pica F, Di Francesco P, Aquaro S, Menichini F, Falconi M, Bianchi L
Drug Design, Development and Therapy 2018, 12:2185-2193
Published Date: 12 July 2018
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
New insight into the pathogenesis of nail psoriasis and overview of treatment strategies
![](cr_data/cache/submission_images/s136000/136986/136986_ventura_fig2_200_200_90.jpg)
Ventura A, Mazzeo M, Gaziano R, Galluzzo M, Bianchi L, Campione E
Drug Design, Development and Therapy 2017, 11:2527-2535
Published Date: 30 August 2017
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Spotlight on ixekizumab for the treatment of moderate-to-severe plaque psoriasis: design, development, and use in therapy
Giunta A, Ventura A, Chimenti MS, Bianchi L, Esposito M
Drug Design, Development and Therapy 2017, 11:1643-1651
Published Date: 2 June 2017
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Efficacy of ingenol mebutate gel for actinic keratosis in patients treated by thiazide diuretics
![](cr_data/cache/submission_images/s111000/111305/111305 figure 2 revised (amended)_200_200_90.jpg)
Campione E, Di Prete M, Diluvio L, Bianchi L, Orlandi A
Clinical, Cosmetic and Investigational Dermatology 2016, 9:405-409
Published Date: 7 November 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The relevance of piroxicam for the prevention and treatment of nonmelanoma skin cancer and its precursors
Campione E, Paternò EJ, Candi E, Falconi M, Costanza G, Diluvio L, Terrinoni A, Bianchi L, Orlandi A
Drug Design, Development and Therapy 2015, 9:5843-5850
Published Date: 29 October 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Tazarotene as alternative topical treatment for onychomycosis
![](cr_data/cache/submission_images/s69000/69946/26_sep_2014_69946_figure_1__200_200_90.jpg)
Campione E, Paternò EJ, Costanza G, Diluvio L, Carboni I, Marino D, Favalli C, Chimenti S, Bianchi L, Orlandi A
Drug Design, Development and Therapy 2015, 9:879-886
Published Date: 16 February 2015